The decline in the incidence of COVID-19 in Russia should not be a reason for refusing vaccination and revaccination. This opinion was expressed on Sunday, May 15, by the director of the Gamaleya Research Center for Epidemiology and Microbiology, Alexander Gintsburg.
According to him, for better protection, it is worth switching to a combination of injection vaccination and revaccination with a nasal preparation.
“Today’s period, when the incidence is declining, should be used as much as possible in order to vaccinate as many people as possible against covid, and also switch to a system of revaccination with a nasal vaccine. It is necessary to combine an injectable drug and an intranasal form, it seems to me that this is our future, ”Gintsburg said.
Earlier, on May 13, it was reported that the level of herd immunity to coronavirus had decreased in Moscow, now this figure is 30.2%.
According to the statistics of the operational headquarters, almost 7.5 million people were vaccinated with the first component of the COVID-19 vaccine in the capital. More than 7.1 million people have been fully vaccinated.
On the same day, it became known about the start of research into a new coronavirus vaccine based on virus-like particles. Gunzburg said that several volunteers had already received the drug, they had no negative reactions to the vaccine.
Prior to this, on May 11, Russian Minister of Health Mikhail Murashko said that the coronavirus infection subsided, but did not completely go away: in Russia, more than 100 thousand people are now sick with COVID-19. He stressed the importance of vaccinating children before the summer holidays to prevent the spread of the disease.
The vaccination campaign continues in Russia. Russians are vaccinated for free. Seven coronavirus drugs have been registered in the country: the world’s first COVID-19 vaccine Sputnik V, Sputnik Light, Sputnik M, EpiVacCorona, EpiVacCorona-N, CoviVac and Convasel.
All relevant information on the situation with coronavirus is available on the sites stopcoronavirus.rf and access to all.rf, as well as on the hashtag #WeTogether. Coronavirus hotline: 8 (800) 2000-112.